Boothbay Fund Management’s Medifast MED Stock Holding History

Boothbay Fund Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-15,323	Closed	-$1.66M	–	2264
2022 Q3	$1.66M	Buy	+15,323	New	+$2.2M	0.04%	649
2020 Q4	–	Sell	-3,848	Closed	-$633K	–	1350
2020 Q3	$633K	Buy	+3,848	New	+$634K	0.04%	575
2020 Q1	–	Sell	-3,640	Closed	-$399K	–	975
2019 Q4	$399K	Buy	+3,640	New	+$352K	0.03%	538
2019 Q2	–	Sell	-9,053	Closed	-$1.16M	–	825
2019 Q1	$1.16M	Buy	+9,053	New	+$1.15M	0.11%	204
2015 Q3	–	Sell	-14,032	Closed	-$454K	–	540
2015 Q2	$454K	Buy	+14,032	New	+$445K	0.18%	115

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Boothbay Fund Management's MED Position: Q4 2022 in Review

Boothbay Fund Management sold out of Medifast (MED) in Q4 2022, closing a stake of 15,323 shares — an estimated $1.66M sold.

Boothbay Fund Management first reported a position in MED in Q2 2015 and held it in 5 quarters. The position peaked at $1.66M in Q3 2022. 277 funds tracked by Wall St. Rank hold MED as of Q4 2022.

Boothbay Fund Management reported no remaining Medifast position as of Q4 2022 after selling out during the quarter.
Boothbay Fund Management sold 15,323 Medifast shares in Q4 2022, an estimated $1.66M.
Boothbay Fund Management first reported a position in Medifast in Q2 2015 and held it in 5 quarters.
Boothbay Fund Management's Medifast position peaked at $1.66M in Q3 2022.
277 funds tracked by Wall St. Rank held Medifast as of Q4 2022.

Based on Boothbay Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.